{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:28:04Z","timestamp":1787099284713,"version":"build-2736575974"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"JSS Academy of Higher Education and Research, Mysore"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"DOI":"10.1186\/s12885-026-16318-2","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T13:36:05Z","timestamp":1781271365000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Methylation-mediated regulation of tumor-suppressor function of the miR-379\/656 (C14MC) cluster and its clinical utility in hepatocellular carcinoma"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1409-0823","authenticated-orcid":false,"given":"Shreyas Hulusemane","family":"Karunakara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-4643-4274","authenticated-orcid":false,"given":"Gopalakrishna","family":"Ramaswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4158-3893","authenticated-orcid":false,"given":"Shama Prasada","family":"Kabekkodu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0383-2366","authenticated-orcid":false,"given":"Akila","family":"Prashant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1582-8057","authenticated-orcid":false,"given":"Prashant","family":"Vishwanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0007-0063","authenticated-orcid":false,"given":"Rohit","family":"Mehtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3338-375X","authenticated-orcid":false,"given":"Prasanna Kumar","family":"Santhekadur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,12]]},"reference":[{"issue":"12","key":"16318_CR1","doi-asserted-by":"publisher","first-page":"1683","DOI":"10.1001\/jamaoncol.2017.3055","volume":"3","author":"T Akinyemiju","year":"2017","unstructured":"Global Burden of Disease Liver Cancer Collaboration, Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu MA, et al. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the Global Burden of Disease Study 2015. JAMA Oncol. 2017;3(12):1683\u201391. https:\/\/doi.org\/10.1001\/jamaoncol.2017.3055.","journal-title":"JAMA Oncol"},{"issue":"6","key":"16318_CR2","doi-asserted-by":"publisher","first-page":"101447","DOI":"10.1016\/j.jceh.2024.101447","volume":"14","author":"S Giri","year":"2024","unstructured":"Giri S, Singh A. Epidemiology of hepatocellular carcinoma in India - an updated review for 2024. J Clin Exp Hepatol. 2024;14(6):101447. https:\/\/doi.org\/10.1016\/j.jceh.2024.101447.","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"16318_CR3","doi-asserted-by":"publisher","first-page":"19217","DOI":"10.1038\/s41598-025-02031-w","volume":"15","author":"Y Zhao","year":"2025","unstructured":"Zhao Y, Peng X, Zhong Z, Pan W, Zheng J, Tian X, et al. Epidemiological and demographic analysis of liver cancer attributable to modifiable risk factors from 1990 to 2021. Sci Rep. 2025;15(1):19217. https:\/\/doi.org\/10.1038\/s41598-025-02031-w.","journal-title":"Sci Rep"},{"key":"16318_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/978-3-319-42059-2_1","volume":"937","author":"S Hombach","year":"2016","unstructured":"Hombach S, Kretz M. Non-coding RNAs: classification, biology and functioning. Adv Exp Med Biol. 2016;937:3\u201317. https:\/\/doi.org\/10.1007\/978-3-319-42059-2_1.","journal-title":"Adv Exp Med Biol"},{"issue":"4","key":"16318_CR5","doi-asserted-by":"publisher","first-page":"195059","DOI":"10.1016\/j.bbagrm.2024.195059","volume":"1867","author":"O Fosseprez","year":"2024","unstructured":"Fosseprez O, Cuvier O. Uncovering the functions and mechanisms of regulatory elements-associated non-coding RNAs. BBA Gene Regul Mech. 2024;1867(4):195059. https:\/\/doi.org\/10.1016\/j.bbagrm.2024.195059.","journal-title":"BBA Gene Regul Mech"},{"key":"16318_CR6","doi-asserted-by":"publisher","first-page":"115527","DOI":"10.1016\/j.biopha.2023.115527","volume":"167","author":"X Zhang","year":"2023","unstructured":"Zhang X, Xu X, Song J, Xu Y, Qian H, Jin J, et al. Non-coding RNAs\u2019 function in cancer development, diagnosis and therapy. Biomed Pharmacother. 2023;167:115527. https:\/\/doi.org\/10.1016\/j.biopha.2023.115527.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"16318_CR7","doi-asserted-by":"publisher","first-page":"361","DOI":"10.3892\/mmr.2022.12878","volume":"26","author":"K Pierouli","year":"2022","unstructured":"Pierouli K, Papakonstantinou E, Papageorgiou L, Diakou I, Mitsis T, Dragoumani K, et al. Long non coding RNAs and microRNAs as regulators of stress in cancer. Mol Med Rep. 2022;26(6):361. https:\/\/doi.org\/10.3892\/mmr.2022.12878.","journal-title":"Mol Med Rep"},{"issue":"1","key":"16318_CR8","doi-asserted-by":"publisher","first-page":"5","DOI":"10.2174\/2772270816666220606112727","volume":"16","author":"G Jothimani","year":"2022","unstructured":"Jothimani G, Bhatiya M, Pathak S, Paul S, Banerjee A. Tumor suppressor microRNAs in gastrointestinal cancers: a mini-review. Recent Adv Inflamm Allergy Drug Discov. 2022;16(1):5\u201315. https:\/\/doi.org\/10.2174\/2772270816666220606112727.","journal-title":"Recent Adv Inflamm Allergy Drug Discov"},{"issue":"10","key":"16318_CR9","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"G Bertoli","year":"2015","unstructured":"Bertoli G, Cava C, Castiglioni I. MicroRNAs: new biomarkers for diagnosis, prognosis, therapy prediction and therapeutic tools for breast cancer. Theranostics. 2015;5(10):1122\u201343. https:\/\/doi.org\/10.7150\/thno.11543.","journal-title":"Theranostics"},{"key":"16318_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.critrevonc.2015.10.003","volume":"98","author":"S Mishra","year":"2016","unstructured":"Mishra S, Yadav T, Rani V. Exploring miRNA based approaches in cancer diagnostics and therapeutics. Crit Rev Oncol Hematol. 2016;98:12\u201323. https:\/\/doi.org\/10.1016\/j.critrevonc.2015.10.003.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"4","key":"16318_CR11","doi-asserted-by":"publisher","first-page":"dmm047662","DOI":"10.1242\/dmm.047662","volume":"14","author":"M Hill","year":"2021","unstructured":"Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021;14(4):dmm047662. https:\/\/doi.org\/10.1242\/dmm.047662.","journal-title":"Dis Model Mech"},{"key":"16318_CR12","doi-asserted-by":"publisher","first-page":"111528","DOI":"10.1016\/j.biopha.2021.111528","volume":"138","author":"BM Hussen","year":"2021","unstructured":"Hussen BM, Hidayat HJ, Salihi A, Sabir DK, Taheri M, Ghafouri-Fard S. MicroRNA: a signature for cancer progression. Biomed Pharmacother. 2021;138:111528. https:\/\/doi.org\/10.1016\/j.biopha.2021.111528.","journal-title":"Biomed Pharmacother"},{"key":"16318_CR13","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000001177","author":"G Song","year":"2024","unstructured":"Song G, Yu X, Shi H, Sun B, Amateau S. miRNAs in HCC, pathogenesis, and targets. Hepatology. 2024. https:\/\/doi.org\/10.1097\/HEP.0000000000001177.","journal-title":"Hepatology"},{"issue":"1","key":"16318_CR14","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/s13045-018-0579-3","volume":"11","author":"S Li","year":"2018","unstructured":"Li S, Yao J, Xie M, Liu Y, Zheng M. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses. J Hematol Oncol. 2018;11(1):54. https:\/\/doi.org\/10.1186\/s13045-018-0579-3.","journal-title":"J Hematol Oncol"},{"key":"16318_CR15","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.3389\/fonc.2020.01271","volume":"10","author":"J Xu","year":"2020","unstructured":"Xu J, An P, Winkler CA, Yu Y. Dysregulated microRNAs in hepatitis B virus-related hepatocellular carcinoma: potential as biomarkers and therapeutic targets. Front Oncol. 2020;10:1271. https:\/\/doi.org\/10.3389\/fonc.2020.01271.","journal-title":"Front Oncol"},{"issue":"2","key":"16318_CR16","doi-asserted-by":"publisher","first-page":"102450","DOI":"10.1016\/j.jceh.2024.102450","volume":"15","author":"SH Karunakara","year":"2025","unstructured":"Karunakara SH, Mehtani R, Kabekkodu SP, Kumar DP, Santhekadur PK. Genes of DLK1-DIO3 locus and miR-379\/656 cluster is a potential diagnostic and prognostic marker in patients with hepatocellular carcinoma: a systems biology study. J Clin Exp Hepatol. 2025;15(2):102450. https:\/\/doi.org\/10.1016\/j.jceh.2024.102450.","journal-title":"J Clin Exp Hepatol"},{"issue":"1","key":"16318_CR17","doi-asserted-by":"publisher","first-page":"9","DOI":"10.18632\/oncotarget.424","volume":"3","author":"N Nohata","year":"2012","unstructured":"Nohata N, Hanazawa T, Enokida H, Seki N. microRNA-1\/133a and microRNA-206\/133b clusters: dysregulation and functional roles in human cancers. Oncotarget. 2012;3(1):9\u201321. https:\/\/doi.org\/10.18632\/oncotarget.424.","journal-title":"Oncotarget"},{"issue":"2","key":"16318_CR18","doi-asserted-by":"publisher","first-page":"e1563","DOI":"10.1002\/wrna.1563","volume":"11","author":"SP Kabekkodu","year":"2020","unstructured":"Kabekkodu SP, Shukla V, Varghese VK, Adiga D, Vethil Jishnu P, Chakrabarty S, et al. Cluster miRNAs and cancer: diagnostic, prognostic and therapeutic opportunities. Wiley Interdiscip Rev RNA. 2020;11(2):e1563. https:\/\/doi.org\/10.1002\/wrna.1563.","journal-title":"Wiley Interdiscip Rev RNA"},{"issue":"1","key":"16318_CR19","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/s13046-021-01910-0","volume":"40","author":"K Yoshida","year":"2021","unstructured":"Yoshida K, Yokoi A, Yamamoto Y, Kajiyama H. ChrXq27.3 miRNA cluster functions in cancer development. J Exp Clin Cancer Res. 2021;40(1):112. https:\/\/doi.org\/10.1186\/s13046-021-01910-0.","journal-title":"J Exp Clin Cancer Res"},{"key":"16318_CR20","doi-asserted-by":"publisher","first-page":"100647","DOI":"10.1016\/j.ctarc.2022.100647","volume":"33","author":"W Zhao","year":"2022","unstructured":"Zhao W, Gupta A, Krawczyk J, Gupta S. The miR-17-92 cluster: yin and yang in human cancers. Cancer Treat Res Commun. 2022;33:100647. https:\/\/doi.org\/10.1016\/j.ctarc.2022.100647.","journal-title":"Cancer Treat Res Commun"},{"key":"16318_CR21","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1186\/1756-0500-3-219","volume":"3","author":"R Neves","year":"2010","unstructured":"Neves R, Scheel C, Weinhold S, Honisch E, Iwaniuk KM, Trompeter HI, et al. Role of DNA methylation in miR-200c\/141 cluster silencing in invasive breast cancer cells. BMC Res Notes. 2010;3:219. https:\/\/doi.org\/10.1186\/1756-0500-3-219.","journal-title":"BMC Res Notes"},{"issue":"3","key":"16318_CR22","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1158\/0008-5472.CAN-18-0692","volume":"79","author":"G Oshima","year":"2019","unstructured":"Oshima G, Poli EC, Bolt MJ, Chlenski A, Forde M, Jutzy JMS, et al. DNA methylation controls metastasis-suppressive 14q32-encoded miRNAs. Cancer Res. 2019;79(3):650\u201362. https:\/\/doi.org\/10.1158\/0008-5472.CAN-18-0692.","journal-title":"Cancer Res"},{"issue":"7","key":"16318_CR23","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3390\/biomedicines9070827","volume":"9","author":"EC McCarthy","year":"2021","unstructured":"McCarthy EC, Dwyer RM. Emerging evidence of the functional impact of the miR379\/miR656 cluster (C14MC) in breast cancer. Biomedicines. 2021;9(7):827. https:\/\/doi.org\/10.3390\/biomedicines9070827.","journal-title":"Biomedicines"},{"issue":"24","key":"16318_CR24","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.3390\/ijms20246285","volume":"20","author":"P Dini","year":"2019","unstructured":"Dini P, El-Sheikh Ali H, Carossino M, Loux SC, Esteller-Vico A, Scoggin KE, et al. Expression profile of the chromosome 14 microRNA cluster ortholog in equine maternal circulation throughout pregnancy and its potential implications. Int J Mol Sci. 2019;20(24):6285. https:\/\/doi.org\/10.3390\/ijms20246285.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"16318_CR25","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1186\/s12864-018-5341-2","volume":"19","author":"P Dini","year":"2018","unstructured":"Dini P, Daels P, Loux SC, Esteller-Vico A, Carossino M, Scoggin KE, et al. Kinetics of the chromosome 14 microRNA cluster ortholog and its potential role during placental development in the pregnant mare. BMC Genomics. 2018;19(1):954. https:\/\/doi.org\/10.1186\/s12864-018-5341-2.","journal-title":"BMC Genomics"},{"issue":"1","key":"16318_CR26","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1007\/s00018-024-05409-7","volume":"81","author":"N Bahram Sangani","year":"2024","unstructured":"Bahram Sangani N, Koetsier J, Gomes AR, Diogo MM, Fernandes TG, Bouwman FG, et al. Involvement of extracellular vesicle microRNA clusters in developing healthy and Rett syndrome brain organoids. Cell Mol Life Sci. 2024;81(1):410. https:\/\/doi.org\/10.1007\/s00018-024-05409-7.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"16318_CR27","doi-asserted-by":"publisher","first-page":"7673","DOI":"10.1038\/s41598-018-26000-8","volume":"8","author":"S Nayak","year":"2018","unstructured":"Nayak S, Aich M, Kumar A, Sengupta S, Bajad P, Dhapola P, et al. Novel internal regulators and candidate miRNAs within miR-379\/miR-656 miRNA cluster can alter cellular phenotype of human glioblastoma. Sci Rep. 2018;8(1):7673. https:\/\/doi.org\/10.1038\/s41598-018-26000-8.","journal-title":"Sci Rep"},{"issue":"1","key":"16318_CR28","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s11060-018-2840-6","volume":"139","author":"A Kumar","year":"2018","unstructured":"Kumar A, Nayak S, Pathak P, Purkait S, Malgulawar PB, Sharma MC, et al. Identification of miR-379\/miR-656 (C14MC) cluster downregulation and associated epigenetic and transcription regulatory mechanism in oligodendrogliomas. J Neurooncol. 2018;139(1):23\u201331. https:\/\/doi.org\/10.1007\/s11060-018-2840-6.","journal-title":"J Neurooncol"},{"issue":"11","key":"16318_CR29","doi-asserted-by":"publisher","first-page":"2686","DOI":"10.3390\/cancers13112686","volume":"13","author":"DE Cohn","year":"2021","unstructured":"Cohn DE, Barros-Filho MC, Minatel BC, Pewarchuk ME, Marshall EA, Vucic EA, et al. Reactivation of multiple fetal miRNAs in lung adenocarcinoma. Cancers. 2021;13(11):2686. https:\/\/doi.org\/10.3390\/cancers13112686.","journal-title":"Cancers"},{"issue":"3","key":"16318_CR30","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/1541-7786.MCR-17-0334","volume":"16","author":"M Gonz\u00e1lez-Vallinas","year":"2018","unstructured":"Gonz\u00e1lez-Vallinas M, Rodr\u00edguez-Paredes M, Albrecht M, Sticht C, Stichel D, Gutekunst J, et al. Epigenetically regulated chromosome 14q32 miRNA cluster induces metastasis and predicts poor prognosis in lung adenocarcinoma patients. Mol Cancer Res. 2018;16(3):390\u2013402. https:\/\/doi.org\/10.1158\/1541-7786.MCR-17-0334.","journal-title":"Mol Cancer Res"},{"issue":"1\u20132","key":"16318_CR31","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s11010-020-03815-6","volume":"473","author":"SJ Tang","year":"2020","unstructured":"Tang SJ, Yang JB. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p\/SIRT5 pathway in hepatocellular carcinoma. Mol Cell Biochem. 2020;473(1\u20132):143\u201353. https:\/\/doi.org\/10.1007\/s11010-020-03815-6.","journal-title":"Mol Cell Biochem"},{"issue":"1","key":"16318_CR32","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.canlet.2016.02.043","volume":"375","author":"JS Chen","year":"2016","unstructured":"Chen JS, Li HS, Huang JQ, Dong SH, Huang ZJ, Yi W, et al. MicroRNA-379-5p inhibits tumor invasion and metastasis by targeting FAK\/AKT signaling in hepatocellular carcinoma. Cancer Lett. 2016;375(1):73\u201383. https:\/\/doi.org\/10.1016\/j.canlet.2016.02.043.","journal-title":"Cancer Lett"},{"issue":"1","key":"16318_CR33","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s12935-023-02893-y","volume":"23","author":"JH Chang","year":"2023","unstructured":"Chang JH, Xu BW, Shen D, Zhao W, Wang Y, Liu JL, et al. BRF2 is mediated by microRNA-409-3p and promotes invasion and metastasis of HCC through the Wnt\/\u03b2-catenin pathway. Cancer Cell Int. 2023;23(1):46. https:\/\/doi.org\/10.1186\/s12935-023-02893-y.","journal-title":"Cancer Cell Int"},{"key":"16318_CR34","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1007\/s12672-025-03834-z","volume":"16","author":"SH Karunakara","year":"2025","unstructured":"Karunakara SH, Moorthy M, Ramaswamy G, et al. Identification of potential oncogenic miRNA clusters with a special focus on miR-106b\/25 cluster-regulated networks and their clinical utility in hepatocellular carcinoma. Discov Onc. 2025;16:2047. https:\/\/doi.org\/10.1007\/s12672-025-03834-z.","journal-title":"Discov Onc"},{"issue":"1","key":"16318_CR35","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s13059-014-0560-6","volume":"16","author":"M Lizio","year":"2015","unstructured":"Lizio M, Harshbarger J, Shimoji H, Severin J, Kasukawa T, Sahin S, et al. Gateways to the FANTOM5 promoter level mammalian expression atlas. Genome Biol. 2015;16(1):22. https:\/\/doi.org\/10.1186\/s13059-014-0560-6.","journal-title":"Genome Biol"},{"issue":"11","key":"16318_CR36","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/bioinformatics\/18.11.1427","volume":"18","author":"LC Li","year":"2002","unstructured":"Li LC, Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics. 2002;18(11):1427\u201331. https:\/\/doi.org\/10.1093\/bioinformatics\/18.11.1427.","journal-title":"Bioinformatics"},{"issue":"21","key":"16318_CR37","doi-asserted-by":"publisher","first-page":"4067","DOI":"10.1093\/bioinformatics\/bti652","volume":"21","author":"C Bock","year":"2005","unstructured":"Bock C, Reither S, Mikeska T, Paulsen M, Walter J, Lengauer T. BiQ Analyzer: visualization and quality control for DNA methylation data from bisulfite sequencing. Bioinformatics. 2005;21(21):4067\u20138. https:\/\/doi.org\/10.1093\/bioinformatics\/bti652.","journal-title":"Bioinformatics"},{"key":"16318_CR38","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/978-1-4939-9904-0_10","volume":"2079","author":"A Goytain","year":"2020","unstructured":"Goytain A, Ng T. NanoString nCounter Technology: High-Throughput RNA Validation. Methods Mol Biol. 2020;2079:125\u201339. https:\/\/doi.org\/10.1007\/978-1-4939-9904-0_10.","journal-title":"Methods Mol Biol"},{"issue":"12","key":"16318_CR39","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8.","journal-title":"Genome Biol"},{"issue":"D1","key":"16318_CR40","doi-asserted-by":"publisher","first-page":"D222","DOI":"10.1093\/nar\/gkab1079","volume":"50","author":"HY Huang","year":"2022","unstructured":"Huang HY, Lin YC, Cui S, Huang Y, Tang Y, Xu J, et al. miRTarBase update 2022: an informative resource for experimentally validated miRNA-target interactions. Nucleic Acids Res. 2022;50(D1):D222\u201330. https:\/\/doi.org\/10.1093\/nar\/gkab1079.","journal-title":"Nucleic Acids Res"},{"issue":"8","key":"16318_CR41","doi-asserted-by":"publisher","first-page":"107269","DOI":"10.1016\/j.isci.2023.107269","volume":"26","author":"HW Wu","year":"2023","unstructured":"Wu HW, Wu JD, Yeh YP, Wu TH, Chao CH, Wang W, Chen TW. DoSurvive: A webtool for investigating the prognostic power of a single or combined cancer biomarker. iScience. 2023;26(8):107269. https:\/\/doi.org\/10.1016\/j.isci.2023.107269.","journal-title":"iScience"},{"issue":"Suppl 4","key":"16318_CR42","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1752-0509-8-S4-S11","volume":"8","author":"CH Chin","year":"2014","unstructured":"Chin CH, Chen SH, Wu HH, Ho CW, Ko MT, Lin CY. cytoHubba: identifying hub objects and sub-networks from complex interactome. BMC Syst Biol. 2014;8(Suppl 4):S11. https:\/\/doi.org\/10.1186\/1752-0509-8-S4-S11.","journal-title":"BMC Syst Biol"},{"issue":"8","key":"16318_CR43","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","volume":"36","author":"SX Ge","year":"2020","unstructured":"Ge SX, Jung D, Yao R. ShinyGO: a graphical gene-set enrichment tool for animals and plants. Bioinformatics. 2020;36(8):2628\u20139. https:\/\/doi.org\/10.1093\/bioinformatics\/btz931.","journal-title":"Bioinformatics"},{"issue":"D1","key":"16318_CR44","doi-asserted-by":"publisher","first-page":"D1004","DOI":"10.1093\/nar\/gkab972","volume":"50","author":"Z Xiong","year":"2022","unstructured":"Xiong Z, Yang F, Li M, Ma Y, Zhao W, Wang G, et al. EWAS Open Platform: integrated data, knowledge and toolkit for epigenome-wide association study. Nucleic Acids Res. 2022;50(D1):D1004\u20139. https:\/\/doi.org\/10.1093\/nar\/gkab972.","journal-title":"Nucleic Acids Res"},{"issue":"2","key":"16318_CR45","doi-asserted-by":"publisher","first-page":"121","DOI":"10.2144\/000113353","volume":"48","author":"H Wiggins","year":"2010","unstructured":"Wiggins H, Rappoport J. An agarose spot assay for chemotactic invasion. Biotechniques. 2010;48(2):121\u20134. https:\/\/doi.org\/10.2144\/000113353.","journal-title":"Biotechniques"},{"issue":"10","key":"16318_CR46","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1038\/s41580-019-0159-6","volume":"20","author":"MVC Greenberg","year":"2019","unstructured":"Greenberg MVC, Bourc\u2019his D. The diverse roles of DNA methylation in mammalian development and disease. Nat Rev Mol Cell Biol. 2019;20(10):590\u2013607. https:\/\/doi.org\/10.1038\/s41580-019-0159-6.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"10","key":"16318_CR47","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1111\/hepr.13932","volume":"53","author":"TH Su","year":"2023","unstructured":"Su TH, Chang SH, Chen CL, Liao SH, Tseng TC, Hsu SJ, et al. Serial increase and high alpha-fetoprotein levels predict the development of hepatocellular carcinoma in 6 months. Hepatol Res. 2023;53(10):1021\u201330. https:\/\/doi.org\/10.1111\/hepr.13932.","journal-title":"Hepatol Res"},{"key":"16318_CR48","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s43055-023-00982-6","volume":"54","author":"AH Abduljabbar","year":"2023","unstructured":"Abduljabbar AH. Diagnostic accuracy of ultrasound and alpha-fetoprotein measurement for hepatocellular carcinoma surveillance: a retrospective comparative study. Egypt J Radiol Nucl Med. 2023;54:31. https:\/\/doi.org\/10.1186\/s43055-023-00982-6.","journal-title":"Egypt J Radiol Nucl Med"},{"issue":"5","key":"16318_CR49","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1002\/hep.32740","volume":"77","author":"R Donne","year":"2023","unstructured":"Donne R, Lujambio A. The liver cancer immune microenvironment: Therapeutic implications for hepatocellular carcinoma. Hepatology. 2023;77(5):1773\u201396. https:\/\/doi.org\/10.1002\/hep.32740.","journal-title":"Hepatology"},{"issue":"7","key":"16318_CR50","doi-asserted-by":"publisher","first-page":"e2420963","DOI":"10.1001\/jamanetworkopen.2024.20963","volume":"7","author":"C Mezzacappa","year":"2024","unstructured":"Mezzacappa C, Kim NJ, Vutien P, Kaplan DE, Ioannou GN, Taddei TH. Screening for Hepatocellular Carcinoma and Survival in Patients With Cirrhosis After Hepatitis C Virus Cure. JAMA Netw Open. 2024;7(7):e2420963. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.20963.","journal-title":"JAMA Netw Open"},{"issue":"11","key":"16318_CR51","doi-asserted-by":"publisher","first-page":"e0581","DOI":"10.1097\/HC9.0000000000000581","volume":"8","author":"D Goldberg","year":"2024","unstructured":"Goldberg D, Reese PP, Kaplan DA, Zarnegarnia Y, Gaddipati N, Gaddipati S, et al. Predicting long-term survival among patients with HCC. Hepatol Commun. 2024;8(11):e0581. https:\/\/doi.org\/10.1097\/HC9.0000000000000581.","journal-title":"Hepatol Commun"},{"issue":"3","key":"16318_CR52","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.gendis.2020.01.014","volume":"7","author":"W Wang","year":"2020","unstructured":"Wang W, Wei C. Advances in the early diagnosis of hepatocellular carcinoma. Genes Dis. 2020;7(3):308\u201319. https:\/\/doi.org\/10.1016\/j.gendis.2020.01.014.","journal-title":"Genes Dis"},{"issue":"12","key":"16318_CR53","doi-asserted-by":"publisher","first-page":"3107","DOI":"10.1158\/1078-0432.CCR-13-3348","volume":"20","author":"E Nadal","year":"2014","unstructured":"Nadal E, Zhong J, Lin J, Reddy RM, Ramnath N, Orringer MB, et al. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma. Clin Cancer Res. 2014;20(12):3107\u201317. https:\/\/doi.org\/10.1158\/1078-0432.CCR-13-3348.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"16318_CR54","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1002\/1878-0261.13611","volume":"18","author":"S Srinath","year":"2024","unstructured":"Srinath S, Jishnu PV, Varghese VK, Shukla V, Adiga D, Mallya S, et al. Regulation and tumor-suppressive function of the miR-379\/miR-656 (C14MC) cluster in cervical cancer. Mol Oncol. 2024;18(6):1608\u201330. https:\/\/doi.org\/10.1002\/1878-0261.13611.","journal-title":"Mol Oncol"},{"key":"16318_CR55","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1476-4598-11-44","volume":"11","author":"L Zehavi","year":"2012","unstructured":"Zehavi L, Avraham R, Barzilai A, Bar-Ilan D, Navon R, Sidi Y, et al. Silencing of a large microRNA cluster on human chromosome 14q32 in melanoma: biological effects of mir-376a and mir-376c on insulin growth factor 1 receptor. Mol Cancer. 2012;11:44. https:\/\/doi.org\/10.1186\/1476-4598-11-44.","journal-title":"Mol Cancer"},{"issue":"4","key":"16318_CR56","doi-asserted-by":"publisher","first-page":"4395","DOI":"10.18632\/oncotarget.10611","volume":"9","author":"S Molina-Pinelo","year":"2016","unstructured":"Molina-Pinelo S, Salinas A, Moreno-Mata N, Ferrer I, Suarez R, Andr\u00e9s-Le\u00f3n E, et al. Impact of DLK1-DIO3 imprinted cluster hypomethylation in smoker patients with lung cancer. Oncotarget. 2016;9(4):4395\u2013410. https:\/\/doi.org\/10.18632\/oncotarget.10611.","journal-title":"Oncotarget"},{"issue":"8","key":"16318_CR57","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1038\/ejhg.2017.91","volume":"25","author":"J Beygo","year":"2017","unstructured":"Beygo J, K\u00fcchler A, Gillessen-Kaesbach G, Albrecht B, Eckle J, Eggermann T, et al. New insights into the imprinted MEG8-DMR in 14q32 and clinical and molecular description of novel patients with Temple syndrome. Eur J Hum Genet. 2017;25(8):935\u201345. https:\/\/doi.org\/10.1038\/ejhg.2017.91.","journal-title":"Eur J Hum Genet"},{"issue":"6","key":"16318_CR58","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1002\/hep.26573","volume":"58","author":"C Yin","year":"2013","unstructured":"Yin C, Wang PQ, Xu WP, Yang Y, Zhang Q, Ning BF, et al. Hepatocyte nuclear factor-4\u03b1 reverses malignancy of hepatocellular carcinoma through regulating miR-134 in the DLK1-DIO3 region. Hepatology. 2013;58(6):1964\u201376. https:\/\/doi.org\/10.1002\/hep.26573.","journal-title":"Hepatology"},{"key":"16318_CR59","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.canlet.2021.11.005","volume":"526","author":"C Sun","year":"2022","unstructured":"Sun C, Jing W, Xiong G, Ma D, Lin Y, Lv X, et al. Inhibiting Src-mediated PARP1 tyrosine phosphorylation confers synthetic lethality to PARP1 inhibition in HCC. Cancer Lett. 2022;526:180\u201392. https:\/\/doi.org\/10.1016\/j.canlet.2021.11.005.","journal-title":"Cancer Lett"},{"issue":"15","key":"16318_CR60","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.3390\/cancers14153806","volume":"14","author":"A Paturel","year":"2022","unstructured":"Paturel A, Hall J, Chemin I. Poly(ADP-Ribose) Polymerase Inhibition as a Promising Approach for Hepatocellular Carcinoma Therapy. Cancers (Basel). 2022;14(15):3806. https:\/\/doi.org\/10.3390\/cancers14153806.","journal-title":"Cancers (Basel)"},{"issue":"7","key":"16318_CR61","doi-asserted-by":"publisher","first-page":"2226","DOI":"10.7150\/jca.66020","volume":"13","author":"H Xu","year":"2022","unstructured":"Xu H, Ma Z, Mo X, Chen X, Xu F, Wu F, et al. Inducing Synergistic DNA Damage by TRIP13 and PARP1 Inhibitors Provides a Potential Treatment for Hepatocellular Carcinoma. J Cancer. 2022;13(7):2226\u201337. https:\/\/doi.org\/10.7150\/jca.66020.","journal-title":"J Cancer"},{"key":"16318_CR62","doi-asserted-by":"publisher","first-page":"285","DOI":"10.2147\/JHC.S447915","volume":"11","author":"JS Pang","year":"2024","unstructured":"Pang JS, Bai XM, Wan WJ, Kang T, Wen R, Li LP, et al. RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer. J Hepatocell Carcinoma. 2024;11:285\u2013304. https:\/\/doi.org\/10.2147\/JHC.S447915.","journal-title":"J Hepatocell Carcinoma"},{"issue":"6","key":"16318_CR63","doi-asserted-by":"publisher","first-page":"101536","DOI":"10.1016\/j.aohep.2024.101536","volume":"29","author":"K Yang","year":"2024","unstructured":"Yang K, Ding Y, Han J, He R. CircROBO1 knockdown improves the radiosensitivity of hepatocellular carcinoma by regulating RAD21. Ann Hepatol. 2024;29(6):101536. https:\/\/doi.org\/10.1016\/j.aohep.2024.101536.","journal-title":"Ann Hepatol"},{"issue":"2","key":"16318_CR64","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1111\/cas.14751","volume":"112","author":"J Wang","year":"2021","unstructured":"Wang J, Zhao H, Yu J, Xu X, Jing H, Li N, et al. MiR-320b\/RAD21 axis affects hepatocellular carcinoma radiosensitivity to ionizing radiation treatment through DNA damage repair signaling. Cancer Sci. 2021;112(2):575\u201388. https:\/\/doi.org\/10.1111\/cas.14751.","journal-title":"Cancer Sci"},{"issue":"1","key":"16318_CR65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s10142-025-01664-4","volume":"25","author":"Z Wang","year":"2025","unstructured":"Wang Z, Wang C. SPP1 promotes malignant characteristics and drug resistance in hepatocellular carcinoma by activating fatty acid metabolic pathway. Funct Integr Genomics. 2025;25(1):151. https:\/\/doi.org\/10.1007\/s10142-025-01664-4.","journal-title":"Funct Integr Genomics"},{"issue":"1","key":"16318_CR66","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.iliver.2023.01.004","volume":"2","author":"J Song","year":"2023","unstructured":"Song J, Sun J, Jing S, Zhang T, Wang J, Liu Y. A high level of secreted phosphoprotein 1 is associated with macrophage infiltration and poor prognosis in hepatocellular carcinoma. iLiver. 2023;2(1):26\u201335. https:\/\/doi.org\/10.1016\/j.iliver.2023.01.004.","journal-title":"iLiver"},{"issue":"16","key":"16318_CR67","doi-asserted-by":"publisher","first-page":"5218","DOI":"10.7150\/ijbs.85656","volume":"19","author":"J Liao","year":"2023","unstructured":"Liao J, Chen Z, Chang R, Yuan T, Li G, Zhu C, et al. CENPA functions as a transcriptional regulator to promote hepatocellular carcinoma progression via cooperating with YY1. Int J Biol Sci. 2023;19(16):5218\u201332. https:\/\/doi.org\/10.7150\/ijbs.85656.","journal-title":"Int J Biol Sci"},{"issue":"5","key":"16318_CR68","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.14218\/JCTH.2023.00034","volume":"11","author":"D Liang","year":"2023","unstructured":"Liang D, Luo L, Wang J, Liu T, Guo C. CENPA-driven STMN1 Transcription Inhibits Ferroptosis in Hepatocellular Carcinoma. J Clin Transl Hepatol. 2023;11(5):1118\u201329. https:\/\/doi.org\/10.14218\/JCTH.2023.00034.","journal-title":"J Clin Transl Hepatol"},{"issue":"5","key":"16318_CR69","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","volume":"144","author":"D Hanahan","year":"2011","unstructured":"Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646\u201374. https:\/\/doi.org\/10.1016\/j.cell.2011.02.013.","journal-title":"Cell"},{"issue":"1","key":"16318_CR70","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of Cancer: New Dimensions. Cancer Discov. 2022;12(1):31\u201346. https:\/\/doi.org\/10.1158\/2159-8290.CD-21-1059.","journal-title":"Cancer Discov"},{"issue":"1","key":"16318_CR71","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12964-020-00628-4","volume":"18","author":"Y Wang","year":"2020","unstructured":"Wang Y, Wang H, Yan Z, Li G, Hu G, Zhang H, et al. The critical role of dysregulated Hh-FOXM1-TPX2 signaling in human hepatocellular carcinoma cell proliferation. Cell Commun Signal. 2020;18(1):116. https:\/\/doi.org\/10.1186\/s12964-020-00628-4.","journal-title":"Cell Commun Signal"},{"key":"16318_CR72","doi-asserted-by":"publisher","first-page":"6181","DOI":"10.2147\/CMAR.S182625","volume":"10","author":"Z Wang","year":"2018","unstructured":"Wang Z, He L, Sun W, Qin Y, Dong W, Zhang T, et al. miRNA-299-5p regulates estrogen receptor alpha and inhibits migration and invasion of papillary thyroid cancer cell. Cancer Manag Res. 2018;10:6181\u201393. https:\/\/doi.org\/10.2147\/CMAR.S182625.","journal-title":"Cancer Manag Res"},{"issue":"4","key":"16318_CR73","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.3892\/or.2020.7486","volume":"43","author":"C Li","year":"2020","unstructured":"Li C, Wang A, Chen Y, Liu Y, Zhang H, Zhou J. MicroRNA 299 5p inhibits cell metastasis in breast cancer by directly targeting serine\/threonine kinase 39. Oncol Rep. 2020;43(4):1221\u201333. https:\/\/doi.org\/10.3892\/or.2020.7486.","journal-title":"Oncol Rep"},{"key":"16318_CR74","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1016\/j.biopha.2017.04.050","volume":"91","author":"K Wang","year":"2017","unstructured":"Wang K, Jin J, Ma T, Zhai H. MiR-376c-3p regulates the proliferation, invasion, migration, cell cycle and apoptosis of human oral squamous cancer cells by suppressing HOXB7. Biomed Pharmacother. 2017;91:517\u201325. https:\/\/doi.org\/10.1016\/j.biopha.2017.04.050.","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"16318_CR75","doi-asserted-by":"publisher","first-page":"3512","DOI":"10.1016\/j.ygeno.2021.07.018","volume":"113","author":"L Zhang","year":"2021","unstructured":"Zhang L, Liu F, Meng Z, Luo Q, Pan D, Qian Y. Inhibited HDAC3 promotes microRNA-376c-3p to suppress malignant phenotypes of gastric cancer cells by reducing WNT2b. Genomics. 2021;113(6):3512\u201322. https:\/\/doi.org\/10.1016\/j.ygeno.2021.07.018.","journal-title":"Genomics"},{"issue":"4","key":"16318_CR76","doi-asserted-by":"publisher","first-page":"878","DOI":"10.5114\/aoms.2019.85244","volume":"16","author":"N Bai","year":"2019","unstructured":"Bai N, Hou D, Mao C, Cheng L, Li N, Mao X. MiR-376c-3p targets heparin-binding EGF-like growth factor to inhibit proliferation and invasion in medullary thyroid carcinoma cells. Arch Med Sci. 2019;16(4):878\u201387. https:\/\/doi.org\/10.5114\/aoms.2019.85244.","journal-title":"Arch Med Sci"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-026-16318-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-026-16318-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:05:38Z","timestamp":1787097938000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12885-026-16318-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,12]]},"references-count":76,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["16318"],"URL":"https:\/\/doi.org\/10.1186\/s12885-026-16318-2","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,12]]},"assertion":[{"value":"15 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study did not include any direct inclusion of animal or human specimens. All the experiments were performed using the established cell line models freely available for research purpose. The source of these cells are disclosed in the manuscript. All the patient data is taken from TCGA public cohort for clinical validation.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"GR is an employee of Theraues Innovations Pvt Ltd, Bengaluru, and is a part of collaboration for this study. The company or the employees hold no reservations whatsoever in terms of the data generated from the study.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"995"}}